Study of Optimizing Neoadjuvant Regimens in Subtypes of Breast Cancer
Status: UNKNOWN
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Neoadjuvant Chemotherapy
Interventions: DRUG: Paclitaxel and carboplatin|DRUG: Paclitaxel|DRUG: Epirubicin and Paclitaxel
Sponsor: Chinese Academy of Medical Sciences